cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pds Biotechnology Corp
3 own
4 watching
Current Price
$8.75
$0.52
(6.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
249.01M
52-Week High
52-Week High
13.65
52-Week Low
52-Week Low
2.89
Average Volume
Average Volume
0.63M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization249.01M
icon52-Week High13.65
icon52-Week Low2.89
iconAverage Volume0.63M
iconDividend Yield--
iconP/E Ratio--
What does the Pds Biotechnology Corp do?
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.
Read More
How much money does Pds Biotechnology Corp make?
News & Events about Pds Biotechnology Corp.
Globe Newswire
8days ago
FLORHAM PARK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced its participation in the Channelchek Takeaway Series...
Globe Newswire
21days ago
FLORHAM PARK, N.J., Jan. 13, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced that its management will participate in a fireside ...
Globe Newswire
1month ago
PDS Biotech bolsters immuno-oncology portfolio with a clinical-stage product synergistic with its Versamune platform PDS Biotech to host conference call and webcast on Tuesday, January 3, 2023, at 8:00 AM EST FLORHAM PARK, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq...
PR Newswire
1month ago
Thinking about buying stock in Lucid Group, Elys Game Technology, Gaotu Techedu, PDS Biotechnology, or Southwest Airlines? Thinking about buying stock in Lucid Group, Elys Game Technology, Gaotu Techedu, PDS Biotechnology, or Southwest Airlines? PR Newswire NEW YORK, Dec. 28, 2022 NEW YORK, Dec...
Globe Newswire
1month ago
Median OS of 21 months in 29 checkpoint inhibitor (CPI) refractory HPV16-positive cancer patients in National Cancer Institute-led Phase 2 clinical trial of PDS0101 triple combinationFLORHAM PARK, N.J., Dec. 28, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage ...
Frequently Asked Questions
Frequently Asked Questions
What is Pds Biotechnology Corp share price today?
plus_minus_icon
Can Indians buy Pds Biotechnology Corp shares?
plus_minus_icon
How can I buy Pds Biotechnology Corp shares from India?
plus_minus_icon
Can Fractional shares of Pds Biotechnology Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Pds Biotechnology Corp stocks?
plus_minus_icon
What is today’s traded volume of Pds Biotechnology Corp?
plus_minus_icon
What is today’s market capitalisation of Pds Biotechnology Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Pds Biotechnology Corp?
plus_minus_icon
What percentage is Pds Biotechnology Corp down from its 52-Week High?
plus_minus_icon
What percentage is Pds Biotechnology Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$8.75
$0.52
(6.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00